172 related articles for article (PubMed ID: 31452794)
1. High WDR34 mRNA expression as a potential prognostic biomarker in patients with breast cancer as determined by integrated bioinformatics analysis.
Hu DJ; Shi WJ; Yu M; Zhang L
Oncol Lett; 2019 Sep; 18(3):3177-3187. PubMed ID: 31452794
[TBL] [Abstract][Full Text] [Related]
2. FoxM1 is a promising candidate target in the treatment of breast cancer.
Lu XF; Zeng D; Liang WQ; Chen CF; Sun SM; Lin HY
Oncotarget; 2018 Jan; 9(1):842-852. PubMed ID: 29416660
[TBL] [Abstract][Full Text] [Related]
3. PBX1 is a valuable prognostic biomarker for patients with breast cancer.
Ao X; Ding W; Ge H; Zhang Y; Ding D; Liu Y
Exp Ther Med; 2020 Jul; 20(1):385-394. PubMed ID: 32565927
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Prostaglandin-Endoperoxide Synthase-2 Expressions in Human Breast Carcinoma: A Multiomic Approach.
Saindane M; Rallabandi HR; Park KS; Heil A; Nam SE; Yoo YB; Yang JH; Yun IJ
Cancer Inform; 2020; 19():1176935120969696. PubMed ID: 33223820
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tryptophan-aspartic acid repeat-containing protein 34 as a novel tumor-suppressor molecule in human oral cancer.
Yamamoto JI; Kasamatsu A; Okubo Y; Nakashima D; Fushimi K; Minakawa Y; Kasama H; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2018 Jan; 495(4):2469-2474. PubMed ID: 29278705
[TBL] [Abstract][Full Text] [Related]
6. Expression patterns of E2F transcription factors and their potential prognostic roles in breast cancer.
Li Y; Huang J; Yang D; Xiang S; Sun J; Li H; Ren G
Oncol Lett; 2018 Jun; 15(6):9216-9230. PubMed ID: 29844824
[TBL] [Abstract][Full Text] [Related]
7. Mining the prognostic significance of the GINS2 gene in human breast cancer using bioinformatics analysis.
Yu S; Zhu L; Xie P; Jiang S; Wang K; Liu Y; He J; Ren Y
Oncol Lett; 2020 Aug; 20(2):1300-1310. PubMed ID: 32724372
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis revealing prognostic significance of
Chen WX; Yang LG; Xu LY; Cheng L; Qian Q; Sun L; Zhu YL
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898978
[No Abstract] [Full Text] [Related]
9. Prognostic roles of signal transducers and activators of transcription family in human breast cancer.
Wang S; Yu L; Shi W; Li X; Yu L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29326301
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns and the prognostic value of the SMYD family members in human breast carcinoma using integrative bioinformatics analysis.
Song J; Liu Y; Chen Q; Yang J; Jiang Z; Zhang H; Liu Z; Jin B
Oncol Lett; 2019 Apr; 17(4):3851-3861. PubMed ID: 30930987
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3B expression and its prognostic potential in breast cancer.
Mao Y; Lv M; Zhang Y; Nie G; Cui J; Wang Y; Wang Y; Cao W; Liu X; Wang X; Wang H
Oncol Lett; 2020 Apr; 19(4):3205-3214. PubMed ID: 32256817
[TBL] [Abstract][Full Text] [Related]
12. Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients.
You Y; Ma Y; Wang Q; Ye Z; Deng Y; Bai F
Cancer Manag Res; 2019; 11():1199-1210. PubMed ID: 30787639
[TBL] [Abstract][Full Text] [Related]
13. SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer.
Huo Q; Li Z; Cheng L; Yang F; Xie N
Front Oncol; 2020; 10():621. PubMed ID: 32528869
[No Abstract] [Full Text] [Related]
14. Erythropoietin-producing hepatocellular A6 overexpression is a novel biomarker of poor prognosis in patients with breast cancer.
Zhou D; Ren K; Wang J; Ren H; Yang W; Wang W; Li Q; Liu X; Tang F
Oncol Lett; 2018 Apr; 15(4):5257-5263. PubMed ID: 29552165
[TBL] [Abstract][Full Text] [Related]
15. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
[TBL] [Abstract][Full Text] [Related]
16. CLIP4 Shows Putative Tumor Suppressor Characteristics in Breast Cancer: An Integrated Analysis.
Fan Y; He L; Wang Y; Fu S; Han Y; Fan J; Wen Q
Front Mol Biosci; 2020; 7():616190. PubMed ID: 33575272
[No Abstract] [Full Text] [Related]
17. Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer.
Tian Y; Liu X; Hu J; Zhang H; Wang B; Li Y; Fu L; Su R; Yu Y
Front Oncol; 2021; 11():703501. PubMed ID: 34513683
[TBL] [Abstract][Full Text] [Related]
18. Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancers.
Park S; Koh E; Koo JS; Kim SI; Park BW; Kim KS
Oncotarget; 2017 Oct; 8(47):82940-82955. PubMed ID: 29137314
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.
Wang J; Ye C; Lu D; Chen Y; Jia Y; Ying X; Xiong H; Zhao W; Zhou J; Wang L
Oncotarget; 2017 Oct; 8(53):91379-91390. PubMed ID: 29207651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
